Alumis Inc reports results for the quarter ended June 30 - Earnings Summary

• Alumis Inc ALMS.OQ reported a quarterly adjusted loss of $1.68​​ per share for the quarter ended June 30, higher than the same quarter last year, when the company reported EPS of $-23.10. The mean expectation of eight analysts for the quarter was for a loss of $1.38 per share. Wall Street expected results to range from $-1.80 to -87 cents per share.

• Revenue was $2.67 million​; analysts expected $2.00 million.

• Alumis Inc's reported EPS for the quarter was 77 cents​.

• The company reported quarterly net income of $59.32 million.

• Alumis Inc shares had risen by 47.3% this quarter and lost 43.8% so far this year.

FORECAST CHANGES

• The mean earnings estimate of analysts had fallen by about 25.2% in the last three months.​

• In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.

RECOMMENDATIONS

• The current average analyst rating on the shares is "strong buy" and the breakdown of recommendations is 8 "strong buy" or "buy," no "hold" and no "sell" or "strong sell." The average consensus recommendation for the biotechnology & medical research peer group is "buy."

• Wall Street's median 12-month price target for Alumis Inc is $18.00, about 75.4% above its last closing price of $4.42

This summary was machine generated from LSEG data August 14 at 04:19 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)